Search

Dave A. Ghatt

Examiner (ID: 9104)

Most Active Art Unit
2854
Art Unit(s)
2854, 3307
Total Applications
428
Issued Applications
393
Pending Applications
6
Abandoned Applications
29

Applications

Application numberTitle of the applicationFiling DateStatus
09/155983 USE OF AT LEAST ONE LIPOAMINO ACID AS A SUBSTANCE P ANTAGONIST IN A COSMETIC FORMULATION FOR SOOTHING AND/OR PROTECTING ALL SKIN TYPES, AND IN PARTICULAR SENSITIVE SKIN Jun 16, 1999 Abandoned
Array ( [id] => 4140658 [patent_doc_number] => 06060450 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-09 [patent_title] => 'Method for treatment of autoimmune diseases' [patent_app_type] => 1 [patent_app_number] => 9/318202 [patent_app_country] => US [patent_app_date] => 1999-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 10 [patent_no_of_words] => 10198 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/060/06060450.pdf [firstpage_image] =>[orig_patent_app_number] => 318202 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/318202
Method for treatment of autoimmune diseases May 24, 1999 Issued
Array ( [id] => 1524034 [patent_doc_number] => 06352997 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-05 [patent_title] => 'Method of improving in-vitro fertilization' [patent_app_type] => B1 [patent_app_number] => 09/303852 [patent_app_country] => US [patent_app_date] => 1999-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10155 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 971 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/352/06352997.pdf [firstpage_image] =>[orig_patent_app_number] => 09303852 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/303852
Method of improving in-vitro fertilization May 2, 1999 Issued
09/290985 COMBINATIONS OF BETA3 AGONISTS AND GROWTH HORMONE SECRETAGOGUES Apr 12, 1999 Abandoned
Array ( [id] => 1441156 [patent_doc_number] => 06335317 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-01 [patent_title] => 'Use of gut-trophic growth factors to improve oxidative status' [patent_app_type] => B1 [patent_app_number] => 09/289259 [patent_app_country] => US [patent_app_date] => 1999-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 8452 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/335/06335317.pdf [firstpage_image] =>[orig_patent_app_number] => 09289259 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/289259
Use of gut-trophic growth factors to improve oxidative status Apr 8, 1999 Issued
Array ( [id] => 4158508 [patent_doc_number] => 06107489 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-22 [patent_title] => 'Extended lifetimes in vivo renin inhibitors' [patent_app_type] => 1 [patent_app_number] => 9/267274 [patent_app_country] => US [patent_app_date] => 1999-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 8413 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/107/06107489.pdf [firstpage_image] =>[orig_patent_app_number] => 267274 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/267274
Extended lifetimes in vivo renin inhibitors Mar 11, 1999 Issued
Array ( [id] => 4286354 [patent_doc_number] => 06180096 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-30 [patent_title] => 'Formulations for protection of peg-interferon alpha conjugates' [patent_app_type] => 1 [patent_app_number] => 9/268423 [patent_app_country] => US [patent_app_date] => 1999-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3276 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/180/06180096.pdf [firstpage_image] =>[orig_patent_app_number] => 268423 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/268423
Formulations for protection of peg-interferon alpha conjugates Mar 11, 1999 Issued
09/254522 PEPTIDE PRODRUGS CONTAINING AN ALPHA-HYDROXYACID LINKER Mar 7, 1999 Abandoned
Array ( [id] => 4086969 [patent_doc_number] => 06017886 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-25 [patent_title] => 'Use of NDF peptide as growth factor for sensory epithelium' [patent_app_type] => 1 [patent_app_number] => 9/255974 [patent_app_country] => US [patent_app_date] => 1999-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 5436 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/017/06017886.pdf [firstpage_image] =>[orig_patent_app_number] => 255974 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/255974
Use of NDF peptide as growth factor for sensory epithelium Feb 22, 1999 Issued
Array ( [id] => 4297975 [patent_doc_number] => 06197926 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-06 [patent_title] => 'Methods for treatment of diabetes using peptide analogues of insulin' [patent_app_type] => 1 [patent_app_number] => 9/255668 [patent_app_country] => US [patent_app_date] => 1999-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 30 [patent_no_of_words] => 9037 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/197/06197926.pdf [firstpage_image] =>[orig_patent_app_number] => 255668 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/255668
Methods for treatment of diabetes using peptide analogues of insulin Feb 22, 1999 Issued
Array ( [id] => 1536374 [patent_doc_number] => 06337318 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-08 [patent_title] => 'Sustained GnRH peptide-release formulation' [patent_app_type] => B1 [patent_app_number] => 09/242635 [patent_app_country] => US [patent_app_date] => 1999-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 4682 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/337/06337318.pdf [firstpage_image] =>[orig_patent_app_number] => 09242635 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/242635
Sustained GnRH peptide-release formulation Feb 18, 1999 Issued
09/251734 NOVEL AMIDE DERIVATIVES AS GROWTH HORMONE SECRETAGOGUES Feb 17, 1999 Abandoned
Array ( [id] => 4287950 [patent_doc_number] => 06211152 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-03 [patent_title] => 'Formulations for peptide release' [patent_app_type] => 1 [patent_app_number] => 9/251411 [patent_app_country] => US [patent_app_date] => 1999-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 3081 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/211/06211152.pdf [firstpage_image] =>[orig_patent_app_number] => 251411 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/251411
Formulations for peptide release Feb 16, 1999 Issued
Array ( [id] => 4408575 [patent_doc_number] => 06239105 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-29 [patent_title] => 'Homeopathic preparations of purified growth hormone' [patent_app_type] => 1 [patent_app_number] => 9/251820 [patent_app_country] => US [patent_app_date] => 1999-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 31 [patent_no_of_words] => 9055 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/239/06239105.pdf [firstpage_image] =>[orig_patent_app_number] => 251820 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/251820
Homeopathic preparations of purified growth hormone Feb 16, 1999 Issued
Array ( [id] => 4337520 [patent_doc_number] => 06333307 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-25 [patent_title] => 'Compounds and method for modulating neurite outgrowth' [patent_app_type] => 1 [patent_app_number] => 9/250059 [patent_app_country] => US [patent_app_date] => 1999-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 23356 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/333/06333307.pdf [firstpage_image] =>[orig_patent_app_number] => 250059 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/250059
Compounds and method for modulating neurite outgrowth Feb 11, 1999 Issued
Array ( [id] => 1550009 [patent_doc_number] => 06346512 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-12 [patent_title] => 'Compounds and methods for modulating cell adhesion' [patent_app_type] => B1 [patent_app_number] => 09/248074 [patent_app_country] => US [patent_app_date] => 1999-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 59 [patent_no_of_words] => 38663 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/346/06346512.pdf [firstpage_image] =>[orig_patent_app_number] => 09248074 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/248074
Compounds and methods for modulating cell adhesion Feb 9, 1999 Issued
Array ( [id] => 4322679 [patent_doc_number] => 06331523 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-18 [patent_title] => 'Method of enhancing the survival of retinal neurons and treating ocular diseases using FGF-5' [patent_app_type] => 1 [patent_app_number] => 9/240952 [patent_app_country] => US [patent_app_date] => 1999-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 23 [patent_no_of_words] => 19997 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/331/06331523.pdf [firstpage_image] =>[orig_patent_app_number] => 240952 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/240952
Method of enhancing the survival of retinal neurons and treating ocular diseases using FGF-5 Jan 28, 1999 Issued
Array ( [id] => 4359318 [patent_doc_number] => 06191115 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-20 [patent_title] => 'C-terminus modified heptapeptide LHRH analogs' [patent_app_type] => 1 [patent_app_number] => 9/232425 [patent_app_country] => US [patent_app_date] => 1999-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14384 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 339 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/191/06191115.pdf [firstpage_image] =>[orig_patent_app_number] => 232425 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/232425
C-terminus modified heptapeptide LHRH analogs Jan 14, 1999 Issued
Array ( [id] => 4308170 [patent_doc_number] => 06242040 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-05 [patent_title] => 'Functional sodium chloride compositions' [patent_app_type] => 1 [patent_app_number] => 9/147523 [patent_app_country] => US [patent_app_date] => 1999-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 2766 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/242/06242040.pdf [firstpage_image] =>[orig_patent_app_number] => 147523 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/147523
Functional sodium chloride compositions Jan 13, 1999 Issued
Array ( [id] => 4295167 [patent_doc_number] => 06197746 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-06 [patent_title] => 'Method of using secretin for treating autism' [patent_app_type] => 1 [patent_app_number] => 9/229208 [patent_app_country] => US [patent_app_date] => 1999-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2602 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/197/06197746.pdf [firstpage_image] =>[orig_patent_app_number] => 229208 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/229208
Method of using secretin for treating autism Jan 12, 1999 Issued
Menu